New Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting

Press/Media: Press / Media

PeriodNov 7 2017 → Nov 8 2017

Media coverage

61

Media coverage

  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletThomasNet
    CountryUnited States
    Date11/8/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletProduct News Network
    CountryUnited States
    Date11/8/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletPR Newswire
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletNasdaq
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletIndia Pharma News
    CountryIndia
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWorldNetDaily
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletTickerTech.com
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletDaily Times Leader
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWALB 10
    CountryGeorgia
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outlet19 Action News
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKOLD-TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWave 3
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWFLX Fox 29
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKXXV-TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKCBD
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWSFA
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKPLC TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKFVE
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletFox 19
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKMOV.com
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWAFF
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWMBF
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletLive 5 WCSC
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKFVS12
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWIS-TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWLOX
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKLTV 7
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKPTV.com
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKCTV 5
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWAND TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWBOY
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletFOX 14 TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletChannel 8 Eyewitness News
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWFMJ 21 - TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKuam News 8
    CountryGuam
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKNDO KNDU
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWTRF
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKUSI.com
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outlet14 WFIE
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outlet3 WRCB-TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKWES NewsWest 9
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKOTV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWMCTV.com
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKOAM TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKSWO
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWTOC TV
    CountryGeorgia
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKait 8
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWLBT
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKTRE
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWBOC TV 16
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWTOL-TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKTEN.com
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletNews 9
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWVNS
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKTVN
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletKHQ Right Now
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWDAM-TV
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletWECT TV-6
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletNektar
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker
  • TitleNew Data Featuring Nektar Therapeutics' Wholly-​Owned Immuno-​Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outletAriva.de
    CountryGermany
    Date11/7/17
    PersonsJoshua Walker
  • TitleNEKTAR THERAPEUTICS : New Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting
    Media name/outlet4 Traders
    CountryUnited States
    Date11/7/17
    PersonsJoshua Walker